Content Providers
Keywords: Cancer or LIPIDMAPS or Metabolism or emergency hospital in hyderabad
-
OpenRiskNet
The main objective of OpenRiskNet is to develop an open e-Infrastructure providing resources and services to a variety of communities requiring risk assessment, including chemicals, cosmetic ingredients, therapeutic agents and nanomaterials.
OpenRiskNet is
* a virtual research environment for...0 events (10 past events)OpenRiskNet https://openrisknet.org/ https://tess.elixir-europe.org/content_providers/openrisknet The main objective of OpenRiskNet is to develop an open e-Infrastructure providing resources and services to a variety of communities requiring risk assessment, including chemicals, cosmetic ingredients, therapeutic agents and nanomaterials. OpenRiskNet is * a virtual research environment for predictive toxicology and chemical and nanomaterial risk assessment, * harmonising access to data and facilitating interoperability of software, * easily deployable to single computers, public and in-house cloud solutions, * addressing the needs of industry and academic researchers, risk assessors, regulators and informed public. OpenRiskNet (Grant Agreement 731075) is a 3-years project funded by the European Commission within the Horizon2020 Programme /system/content_providers/images/000/000/097/original/ORN-Web_Logo3.png?1533933310 -
LIPID MAPS
LIPID Metabolites And Pathways Strategy (LIPID MAPS®) is a multi-institutional supported website and database that provides access to a large number of globally used lipidomics resources. LIPID MAPS® has internationally led the field of lipid curation, classification, and nomenclature since 2003....
5 training materials0 events (1 past event)LIPID MAPS https://www.lipidmaps.org/ https://tess.elixir-europe.org/content_providers/lipid-maps-8d2f062e-3051-4752-ba8d-0626399e2e91 LIPID Metabolites And Pathways Strategy (LIPID MAPS®) is a multi-institutional supported website and database that provides access to a large number of globally used lipidomics resources. LIPID MAPS® has internationally led the field of lipid curation, classification, and nomenclature since 2003. We strive to produce new open-access databases, informatics tools and lipidomics-focused training activities will be generated and made publicly available for researchers studying lipids in health and disease. LIPID MAPS® Lipidomics Gateway was created in 2003 via an NIH “Glue Grant” to provide access to lipid nomenclature, databases, tools, protocols, standards, tutorials, meetings, publications, and other resources to serve the international lipid research community. LIPID MAPS® is currently funded by a multi-institutional grant from Wellcome, held jointly by Cardiff University, University of California San Diego, the Babraham Institute Cambridge, and Swansea University, as well as an Innovation Study funded by ELIXIR. LIPID MAPS® supports researchers to conduct integrative systems-level analyses of lipidomics in physiology and pathophysiology. /system/content_providers/images/000/000/672/original/LM_logo.jpg?1681981489 -
EOSC4Cancer
EOSC4Cancer will make diverse types of cancer data accessible: genomics, imaging, medical, clinical, environmental and socio-economic. It will use and enhance federated and interoperable systems for securely identifying, sharing, processing and reusing FAIR data across borders and offer them via...
1 training material0 events (1 past event)EOSC4Cancer https://eosc4cancer.eu/ https://tess.elixir-europe.org/content_providers/eosc4cancer EOSC4Cancer will make diverse types of cancer data accessible: genomics, imaging, medical, clinical, environmental and socio-economic. It will use and enhance federated and interoperable systems for securely identifying, sharing, processing and reusing FAIR data across borders and offer them via community-driven analysis environments. EOSC4Cancer’s well curated data sets will be essential input for reproducible and robust analytics and computational methods – including machine learning and artificial intelligence. EOSC4Cancer’s five use cases will cover the patient journey from cancer prevention over diagnosis to treatment, laying the foundation of data trajectories and workflows for future European Cancer Mission projects. /system/content_providers/images/000/000/747/original/Logo-eosc-cancer-RGB-horizontal-STANDARD.png?1711439233